| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |